Date:
18 September
The KCNC1 Foundation funds research towards a treatment for the rare V434L variant in the KCNC1 gene, associated with KCNC1 developmental and epileptic encephalopathy. Metrion have been working with The KCNC1 Foundation and Perlara to help identify potential therapies by screening The Broad’s repurposed compound library collection against the Kv3.1 V434L variant.
This webinar presents the patient perspective, electrophysiological research, and technologies used as we work towards a potential treatment for KCNC1-related disorders.
Venue and Location Information:
Webinar
Event Registration Link: